{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:13:10Z","timestamp":1791411190786,"version":"4.3.3"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1124\/jpet.111.188508","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T15:32:37Z","timestamp":1321457557000},"page":"422-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity"],"prefix":"10.1016","volume":"340","author":[{"given":"Chi C.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Wing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis P.","family":"Constantinides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Rigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.188508_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.111.188508_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1124\/jpet.111.188508_bib3","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"key":"10.1124\/jpet.111.188508_bib4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/sj.bjc.6690364","article-title":"CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissues","volume":"80","author":"Guichard","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1124\/jpet.111.188508_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/138955709787001695","article-title":"Prodrug designing of NSAIDs","volume":"9","author":"Halen","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"10.1124\/jpet.111.188508_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10709-010-9438-z","article-title":"Mammalian carboxylesterase 3: comparative genomics and proteomics","volume":"138","author":"Holmes","year":"2010","journal-title":"Genetica"},{"key":"10.1124\/jpet.111.188508_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules"},{"key":"10.1124\/jpet.111.188508_bib8","first-page":"837","article-title":"The differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin","volume":"35","author":"Hua","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1124\/jpet.111.188508_bib9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1476-5381.2010.01162.x","article-title":"The novel phospho-non-steroidal anti-inflammatory drugs, OXT-328, MDC-22 and MDC-917, inhibit adjuvant-induced arthritis in rats","volume":"162","author":"Huang","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.188508_bib10","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/carcin\/bgq149","article-title":"Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox\/polyamine-dependent effect","volume":"31","author":"Huang","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1124\/jpet.111.188508_bib11","doi-asserted-by":"crossref","first-page":"17235","DOI":"10.1073\/pnas.0909282106","article-title":"Discovery and validation of colonic tumor-associated proteins via metabolic labeling and stable isotopic dilution","volume":"106","author":"Huttlin","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.111.188508_bib12","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1158\/1535-7163.MCT-06-0160","article-title":"Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity","volume":"5","author":"Hyatt","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.111.188508_bib13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/bbrc.2002.6547","article-title":"Proteome analysis of hepatocellular carcinoma","volume":"291","author":"Lim","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.111.188508_bib14","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1053\/j.gastro.2010.06.044","article-title":"Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice","volume":"139","author":"Mackenzie","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.111.188508_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.2010.084657","article-title":"Carboxylesterase 1 (Ces1): from monocyte marker to major player","volume":"64","author":"Markey","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1124\/jpet.111.188508_bib16","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/pmic.200900105","article-title":"Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma","volume":"9","author":"Na","year":"2009","journal-title":"Proteomics"},{"key":"10.1124\/jpet.111.188508_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jbt.20214","article-title":"Liver prenylated methylated protein methyl esterase is the same enzyme as Sus scrofa carboxylesterase","volume":"22","author":"Oboh","year":"2008","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1124\/jpet.111.188508_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1359-6446(05)03383-0","article-title":"Mammalian carboxylesterases: from drug targets to protein therapeutics","volume":"10","author":"Redinbo","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.111.188508_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.pharmtox.38.1.257","article-title":"The mammalian carboxylesterases: from molecules to functions","volume":"38","author":"Satoh","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.111.188508_bib20","first-page":"18","article-title":"Epidemiology of NSAID induced gastrointestinal complications","volume":"56","author":"Singh","year":"1999","journal-title":"J Rheumatol Suppl"},{"key":"10.1124\/jpet.111.188508_bib21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1124\/jpet.111.183533","article-title":"Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agents","volume":"338","author":"Sun","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.188508_bib22","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1158\/0008-5472.CAN-08-2010","article-title":"The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents","volume":"68","author":"Sun","year":"2008","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.111.188508_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/07357900701560786","article-title":"Carboxylesterase 2 is downregulated in colorectal cancer following progression of the disease","volume":"26","author":"Tang","year":"2008","journal-title":"Cancer Invest"},{"key":"10.1124\/jpet.111.188508_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0026-895X(24)23139-4","article-title":"Structural constraints affect the metabolism of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) by carboxylesterases","volume":"60","author":"Wadkins","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.111.188508_bib25","article-title":"The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine","author":"Xie","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.188508_bib26","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/jpet.111.180224","article-title":"Phospho-ibuprofen (MDC-917) is a novel agent against colon cancer: efficacy, metabolism, and pharmacokinetics in mouse models","volume":"337","author":"Xie","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.188508_bib27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1124\/dmd.30.5.541","article-title":"Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression","volume":"30","author":"Xie","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.111.188508_bib28","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1124\/dmd.111.041335","article-title":"Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human","volume":"39","author":"Williams","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.111.188508_bib29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/carcin\/bgp015","article-title":"Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect","volume":"30","author":"Zhao","year":"2009","journal-title":"Carcinogenesis"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.188508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:42:10Z","timestamp":1740019330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524467323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0022356524467323"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.188508","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.188508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}